APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy George LauMing-Lung YuMasao Omata Guidelines 24 August 2021 Pages: 1031 - 1048
Connection between HPS and ACLF: a solution of chaos? Hitoshi MaruyamaShuichiro Shiina Editorial 04 October 2021 Pages: 1049 - 1052
Effect of microbiota metabolites on the progression of chronic hepatitis B virus infection Xiu SunCalvin Q. PanHuichun Xing Review Article 01 October 2021 Pages: 1053 - 1067
The global trends and regional differences in incidence and mortality of hepatitis A from 1990 to 2019 and implications for its prevention Guiying CaoWenzhan JingMin Liu Original Article Open access 03 August 2021 Pages: 1068 - 1082
Impact of tenofovir alafenamide vs. entecavir on hepatocellular carcinoma risk in patients with chronic hepatitis B Hye Won LeeYoung Youn ChoSoo Young Park Original Article 16 August 2021 Pages: 1083 - 1092
Diabetes is associated with poor short-term prognosis in patients with hepatitis B virus-related acute-on-chronic liver failure Han HuXinxin HuShide Lin Original Article 10 August 2021 Pages: 1093 - 1102
Efficacy and safety of tenofovir disoproxil fumarate and tenofovir alafenamide fumarate in preventing HBV vertical transmission of high maternal viral load Baijun LiZhaozhe LiuYan Wang Original Article 26 July 2021 Pages: 1103 - 1108
Long-term outcome of liver complications in patients with chronic HBV/HCV co-infection after antiviral therapy: a real-world nationwide study on Taiwanese Chronic Hepatitis C Cohort (T-COACH) Ming-Lun YehChao-Hung HungMing-Lung Yu Original Article 07 August 2021 Pages: 1109 - 1121
Hepatic stellate cells-specific LOXL1 deficiency abrogates hepatic inflammation, fibrosis, and corrects lipid metabolic abnormalities in non-obese NASH mice Aiting YangXuzhen YanHong You Original Article 20 May 2021 Pages: 1122 - 1135
First-in-Asian double-blind randomized trial to assess the efficacy and safety of insulin sensitizer in nonalcoholic steatohepatitis patients Jee-Fu HuangChia-Yen DaiWan-Long Chuang Original Article 12 August 2021 Pages: 1136 - 1147
Histological severity of nonalcoholic fatty liver disease is associated with 10-year risk for atherosclerotic cardiovascular disease Ji Hye ParkBo Kyung KooOn behalf of the Innovative Target Exploration of NAFLD (ITEN) Consortium Original Article 03 June 2021 Pages: 1148 - 1159
The differential activation of cardiovascular hormones across distinct stages of portal hypertension predicts clinical outcomes Lukas HartlMathias JachsThomas Reiberger Original Article Open access 21 May 2021 Pages: 1160 - 1173
Increased risk of cancer in patients with primary sclerosing cholangitis Aiva Lundberg BåveAnnika BergquistCaroline Nordenvall Original Article Open access 06 August 2021 Pages: 1174 - 1182
Portal vein thrombosis associated with high 14-day and 6-week rebleeding in patients after oesophageal variceal band ligation: a retrospective, multicentre, nested case–control study Zhanjuan GaoJingrun ZhaoYanjing Gao Original Article 22 July 2021 Pages: 1183 - 1195
A network meta-analysis of direct oral anticoagulants for portal vein thrombosis in cirrhosis Cheng Han NgDarren Jun Hao TanMark D. Muthiah Original Article 21 August 2021 Pages: 1196 - 1206
Hepatopulmonary syndrome is related to the development of acute-on-chronic liver failure and poor prognosis in cirrhotic patients Seul Ki HanMoon Young KimSoon Koo Baik Original Article 28 July 2021 Pages: 1207 - 1214
Survival analysis between laparoscopic and open hepatectomy for hepatocellular carcinoma: a meta-analysis based on reconstructed time-to-event data Qiang SunXiangda ZhangYajin Chen Original Article 13 July 2021 Pages: 1215 - 1235
Targeted inhibition of FGF19/FGFR cascade improves antitumor immunity and response rate in hepatocellular carcinoma David Wai Meng TaiThi Bich Uyen LeHung Huynh Original Article 31 July 2021 Pages: 1236 - 1246
Iodized oil computed tomography versus ultrasound-guided radiofrequency ablation for early hepatocellular carcinoma Chih-Horng WuPo-Chin LiangJia-Horng Kao Original Article 02 August 2021 Pages: 1247 - 1257
Volumetric assessment and clinical predictors of cirrhosis in patients undergoing hepatectomy for hepatocellular carcinoma with presumed normal liver function Takayuki ShimizuTaku AokiKeiichi Kubota Original Article 23 August 2021 Pages: 1258 - 1267
Efficacy of apatinib in patients with sorafenib–transarterial chemoembolization refractory hepatocellular carcinoma: a retrospective study Yanyan CaoTao OuyangChuansheng Zheng Original Article 20 August 2021 Pages: 1268 - 1277
Clinical course of liver injury induced by immune checkpoint inhibitors in patients with advanced malignancies Takanori ItoMasatoshi IshigamiMitsuhiro Fujishiro Original Article 09 August 2021 Pages: 1278 - 1287